Harvard Medical School and Merck & Co. to Advance Cancer and CNS Research
Funding will be provided for six HMS labs.!--h2>
Harvard Medical School’s (HMS) Office of Technology Development and Merck & Co. signed a cooperative research agreement under which the partners will jointly advance research programs in oncology and central nervous system disorders.
Funding will be provided for six HMS labs. Scientists from HMS and Merck will work collaboratively in an effort to unify the program’s goals.